• search
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Discovery Chemistry Services

Discovery Chemistry Services

We offer stand alone and integrated chemistry services for all therapeutic areas spanning different chemical modalities i.e. small molecules, peptides, PROTACs, oligonucleotides, ADC, lipid linkers etc.

At Aurigene Pharmaceutical Services, we offer solutions for all kinds of synthetic chemistry challenges, leveraging our expertise in synthetic chemistry as well as our thorough understanding of various aspects of drug discovery research. With a combination of 600+ highly skilled scientists and a state-of-the-art infrastructure spanned over two sites at Bangalore and Hyderabad, we can support all your synthetic chemistry needs. The team is well-versed in the synthesis of NCEs at all scales, from milligram quantity for a simple primary in vitro Biology and ADME screening needs, to gram scale synthesis for advanced profiling leading to IND filings.

Our discovery chemistry services encompasses heterocyclic chemistry, focused- libraries, peptides, PROTACs, lipids and oligonucleotides. With 40 modular labs equipped with synthesizers and advanced purification instruments, together with a well-equipped analytical infrastructure, we provide the best-in-class medicinal chemistry services to various biotech, pharmaceutical, agrochemical and specialty chemical companies. We are uniquely poised to be a perfect research partner for all your Drug Discovery needs, with a completely digitalized documentation process and compound management facility, an in-house stock of >50000 chemicals and our expertise in providing secure intellectual property.

Speak to our experts

Synthetic Chemistry Services

  • Design-to-Delivery support across various chemistry platforms
  • Milligram-scale to Gram-scale delivery of NCEs
  • Expertise in solving complex chemistry challenges
  • Experienced in parallel catalyst and ligand screening leading to quick resolution of synthetic bottlenecks

Peptide Services

  • One stop solution for end to end (discovery-development-manufacturing) services in peptide space
  • Proven track record of running integrated peptide drug discovery programs
  • Close to two decades of experience in dealing with complex peptide modifications including peptide conjugation
  • Long standing collaboration with leading peptide players

Focused Library Synthesis

  • Experienced in generating small to medium-sized custom libraries
  • In-house collection of building blocks to support custom libraries
  • Parallel purification using Mass-Directed HPLC for high throughput


  • A decade of experience working with PROTACs and molecular glues
  • Analytical team well-versed in the purification of PRTOACs
  • In-house library of Partial PROTACs for quick target engagement


  • Experience in synthesizing 10-60-mer oligonucleotides
  • Synthesis of ASO, Aptamers and Si-RNAs
  • Customized phosphoramidites and post-synthesis modifications

Niche Chemistry Areas

  • Photo-redox and Organo-Electrochemistry
  • C-H activation chemistry
  • C-Si, C-P and C-Se bond-forming reactions
  • Carbohydrates and nucleoside chemistries
  • Steroids and Lipids
  • Labelled compounds and Isotopes

Why Aurigene Pharmaceutical Services?

90% of talent is PG or above

Integration of chemistry to biology and CDMO

State-of-the art facilities and modern infrastructure

Data driven decision making- CADD, informatics, advanced software platforms

50K+ compound inventory management system

Integrated Services

Co-located Teams

20+ Years of legacy

Target identification to commercial manufacturing

Virtual Tour


Contact Us

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

JUNE 28, 2022

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen specific T cells for cellular cancer immunotherapy An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence...

Read More

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contr...

Read More

Technology meets sustainability - How a complex API development process goes green

We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug


Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.